1. Home
  2. Analysis
  3. Janumet-xr
  4. Cozaar

Janumet xr and Cozaar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 18 people who take Janumet xr and Cozaar. Common interactions include diarrhoea among females, and diarrhoea among males.

The phase IV clinical study analyzes what interactions people who take Janumet xr and Cozaar have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

18 people who take Janumet xr and Cozaar together, and have interactions are studied.

What is Janumet xr?

Janumet xr has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is used in type 2 diabetes. Currently, eHealthMe is studying from 2,257 Janumet xr users.

What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is used in high blood pressure. Currently, eHealthMe is studying from 44,472 Cozaar users.

Number of Janumet xr and Cozaar reports submitted per year:

Janumet xr and Cozaar drug interactions.

Common Janumet Xr and Cozaar drug interactions by gender *:

female:

  1. Diarrhoea
  2. Blood glucose increased
  3. Asthenia
  4. Syncope
  5. Abdominal distension
  6. Flatulence
  7. Increased appetite
  8. Adverse drug reaction
  9. Burning sensation
  10. Chronic kidney disease

male:

  1. Diarrhoea
  2. Blood glucose increased
  3. Atrial fibrillation
  4. Cerebrovascular accident
  5. Cognitive disorder
  6. Colitis ischaemic
  7. Cytokine release syndrome
  8. Diffuse large b-cell lymphoma
  9. Disseminated intravascular coagulation
  10. Electrolyte imbalance

Common Janumet Xr and Cozaar drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal discomfort
  2. Blood glucose increased
  3. Burning sensation
  4. Diarrhoea
  5. Pain

60+:

  1. Diarrhoea
  2. Blood glucose increased
  3. Atrial fibrillation
  4. Cerebrovascular accident
  5. Cognitive disorder
  6. Colitis ischaemic
  7. Cytokine release syndrome
  8. Diffuse large b-cell lymphoma
  9. Disseminated intravascular coagulation
  10. Electrolyte imbalance

Common conditions people have *:

  1. Diabetes: 7 people, 38.89%
  2. Urinary Tract Infection: 2 people, 11.11%
  3. Multiple Myeloma (cancer of the plasma cells): 2 people, 11.11%
  4. Stress And Anxiety: 1 person, 5.56%
  5. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.56%
  6. Neoplasm Malignant (cancer tumour): 1 person, 5.56%
  7. Lower Limb Fracture: 1 person, 5.56%
  8. High Blood Cholesterol: 1 person, 5.56%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Janumet xr and Cozaar?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Janumet xr drug interactions:

Browse interactions between Janumet xr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cozaar drug interactions:

Browse interactions between Cozaar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride; sitagliptin phosphate and losartan potassium (the active ingredients of Janumet xr and Cozaar, respectively), and Janumet xr and Cozaar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Janumet xr and Cozaar.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.